Abstract purpose: To determine whether patients with multiple endocrine neoplasia type I
(MEN-I) can initially present with Zollinger-Ellison syndrome (ZES), and to learn whether …

In patients with multiple endocrine neoplasia type 1 (MEN1), the most common functional
pancreatic endocrine tumor (PET) syndrome is Zollinger-Ellison syndrome (ZES). ZES has …

Background. The long-term prognosis of Zollinger-Ellison Syndrome (ZES) is not well
defined. The findings of other endocrinopathies, the need for long-term surveillance, and the …

Mignon M, Cadiot G (Bichat and Claude Bernard Hospital, Paris, France). Diagnostic and
therapeutic criteria in patients with Zollinger–Ellison syndrome and multiple endocrine …

The clinical evolution of type I multiple endocrine neoplasia (MEN I) was studied in 45
patients among a consecutive series of 172 with Zollinger-Ellison syndrome (ZES). These …

Jensen RT (Bethesda, MD, USA). Management of the Zollinger–Ellison syndrome in patients
with multiple endocrine neoplasia type 1 (Minisymposium: MEN & VHL). J Intern Med 1998; …

Context: Multiple endocrine neoplasia type 1 (MEN1) patients frequently develop Zollinger-
Ellison syndrome (ZES). These patients can develop proliferative changes of gastric …

Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …

Enterochromaffin-like (ECL) tumors are documented in patients with hypergastrinemia
secondary to chronic atrophic gastritis or with Zollinger-Ellison syndrome and multiple …

Despite general awareness of Zollinger-Ellison syndrome (ZES) by most physicians and
more than 3000 articles written about it since 1955, the diagnosis of ZES is still delayed for a …